Evidence map›Paper›PMID 35125538›Full record

ArticleBulletin of the World Health Organization2022

Access to eye care during the COVID-19 pandemic, India.

Janani Muralikrishnan, Josephine S Christy, Kavitha Srinivasan, Ganesh-Babu B Subburaman, Aakriti Garg Shukla, Rengaraj Venkatesh, Thulasiraj D Ravilla

Open access · diamondAbstract read
In one paragraph

Article in Bulletin of the World Health Organization, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Impact of Covid-19 on Pediatric Ophthalmology Care: Lessons Learned.Pediatric health, medicine and therapeutics · 2023
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Janani MuralikrishnanDepartment of Paediatrics, Aravind Eye Hospital, Pondicherry, India.
Josephine S ChristyDepartment of Cornea and Refractive Services, Aravind Eye Hospital, Pondicherry, India.
Kavitha SrinivasanDepartment of Glaucoma, Aravind Eye Hospital, Pondicherry, India.
Ganesh-Babu B SubburamanDepartment of Central Operations, Aravind Eye Care System, Madurai, India.
Aakriti Garg ShuklaGlaucoma Service, Wills Eye Hospital, Philadelphia, United States of America.
Rengaraj VenkateshDepartment of Glaucoma, Aravind Eye Hospital, Pondicherry, India.
Thulasiraj D RavillaLions Aravind Institute of Community Ophthalmology, Aravind Eye Care System, 72 Kuruvukaran Salai, Annanagar, Madurai, Tamil Nadu, 625020, India.
Aravind Eye Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo study the impact of the coronavirus disease 2019 (COVID-19) pandemic on outpatient visits to eye care facilities in south India.

methodsWe used data on 7.69 million outpatient visits to primary (i.e. vision centres), secondary and tertiary Aravind Eye Care System's centres between January 2019 and June 2021. We compared outpatient numbers and outpatients' age and sex between the pandemic period and the pre-pandemic period in 2019 for all centres, whereas vision and ophthalmic assessments were compared for vision centres only.

findingsDuring the first wave, the number of outpatient visits at tertiary, secondary and vison centres was 39% (647 968/1 656 296), 60% (170 934/283 176) and 73% (180 502/246 282) respectively, of 2019 levels. During the second wave, outpatient visits at tertiary, secondary and vision centres were 54% (385 092/710 949), 73% (88 383/121 739) and 79% (121 993/154 007), respectively, of 2019 levels. The proportion of outpatients who were female or younger than 20 years or older than 60 years was significantly lower during the first and second waves than in 2019 (

conclusionRestrictive measurements led to declines in outpatient visits, however the decline was less at secondary and vision centres than at tertiary centres. Easy access to specialized ophthalmic care via telemedicine and the relative proximity of these centres to communities helped reduce barriers to access.

Indexed as

COVID-19TelemedicineFemaleHumansOutpatientsPandemicsSARS-CoV-2

Identifiers

PMID35125538
PMCPMC8795846
OpenAlexW4210904906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.